Atlas Trials

A Phase I Multiple Dose Pharmacokinetic Study of Nevirapine Extended Release (XR) in HIV-1 Infected Children.

Clinical trial NCT00905489 · COMPLETED

Trial details

NCT number
NCT00905489
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
HIV Infections
Start date
2009-06-01
Primary completion
2012-09-01
Enrollment
85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.